Piao, W <br/><br/>
Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells.  [electronic resource] 

 -  Biochemical pharmacology  Dec 2001 
 - 1439-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/s0006-2952(01)00796-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>CDC2 Protein Kinase--metabolism<br/>Caspase 3<br/>Caspases--metabolism<br/>Cell Division--drug effects<br/>Down-Regulation--drug effects<br/>Enzyme Activation--drug effects<br/>G2 Phase--drug effects<br/>HL-60 Cells<br/>Humans<br/>Imidazoles--pharmacology<br/>Leukemia, Promyelocytic, Acute<br/>Mitosis--drug effects<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly(ADP-ribose) Polymerases<br/>Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>Sulfones--pharmacology